Search filters

Once-daily dolutegravir is superior to once-daily darunavir/ritonavir in treatment-naïve HIV-1-positive individuals: 96 week results from FLAMINGO

Image Image of a generic work. The text above it indicates that there is no free image of the work available, and that if you own one, you can click on the placeholder link to upload it.
Description scientific article published on 2 November 2014
Author/s

author: Matthias Cavassini  Jean-Michel Molina  Bonaventura Clotet Sala  Adriano Lazzarin  Jan van Lunzen 

Publication date November 2, 2014
Language English
Country of origin
Wikipedia link
Copyright status
Missing/wrong data? Edit Wikidata item